Bactériologie médicale, Techniques usuelles, 2ème édition, 2011. ,
Chapitre 16 -?-lactamines et entérobactéries, Antibiogramme, 3ème édition., Paris: Editions Eska, pp.165-188, 2012. ,
« Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: an international expert proposal for interim standard definitions for acquired resistance, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.18, issue.3, pp.268-281, 2012. ,
« CTX-M-type ?lactamases: A successful story of antibiotic resistance, Int. J. Med. Microbiol, vol.303, pp.6-7, 2013. ,
Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum ??-lactamases (ESBLs), Clinical Microbiology and Infection, vol.6, issue.9, pp.460-463, 2000. ,
DOI : 10.1046/j.1469-0691.2000.00107.x
Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae, Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae, pp.5131-5133 ,
DOI : 10.1128/AAC.00607-13
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum ??-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae, Infectious Diseases and Therapy, vol.17, issue.12, pp.65-83, 2015. ,
DOI : 10.1111/j.1469-0691.2011.03514.x
Carbapenem resistance in Enterobacteriaceae: here is the storm!, Trends in Molecular Medicine, vol.18, issue.5, pp.263-272, 2012. ,
DOI : 10.1016/j.molmed.2012.03.003
Resistance in Gram-Negative Bacteria: Enterobacteriaceae, The American Journal of Medicine, vol.119, issue.6, pp.20-28, 2006. ,
DOI : 10.1016/j.amjmed.2006.03.013
The population genetics of commensal Escherichia coli, Nature Reviews Microbiology, vol.75, issue.3, pp.207-217, 2010. ,
DOI : 10.1016/j.tig.2007.12.007
Evidence for Coexistence of Distinct Escherichia coli Populations in Various Aquatic Environments and Their Survival in Estuary Water, Applied and Environmental Microbiology, vol.79, issue.15, pp.15-4684, 2013. ,
DOI : 10.1128/AEM.00698-13
phylo-typing method revisited: improvement of specificity and detection of new phylo-groups, Environmental Microbiology Reports, vol.1, issue.1, pp.58-65 ,
DOI : 10.1128/AEM.01262-09
Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem, Microbes and Infection, vol.5, issue.5, pp.449-456, 2003. ,
DOI : 10.1016/S1286-4579(03)00049-2
Investigation et de Surveillance des Infections Nosocomiales, « Enquête nationale de prévalence des infections nosocomiales et des traitements anti-infectieux en établissements de santé français, p.2012 ,
Klebsiella pneumoniae MrkD-mediated biofilm formation on extracellular matrix- and collagen-coated surfaces, Microbiology, vol.149, issue.9, pp.2397-2405, 2003. ,
DOI : 10.1099/mic.0.26434-0
Environmental contamination with extended-spectrum ??-lactamases: Is there any difference between Escherichia coli and Klebsiella spp?, American Journal of Infection Control, vol.40, issue.9, pp.845-848, 2012. ,
DOI : 10.1016/j.ajic.2011.10.007
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current ??-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?, Clinical Infectious Diseases, vol.58, issue.8, pp.1072-1083 ,
DOI : 10.1093/cid/ciu027
Evolution of extended-spectrum beta-lactamases by mutation, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.14, 2008. ,
Ubertragbare Resistenz gegen??ber Cefotaxim, Cefoxitin, Cefamandol und Cefuroxim in klinischen Isolaten von Klebsiella pneumoniae und Serratia marcescens, Infection, vol.147, issue.6, pp.315-317, 1983. ,
DOI : 10.1007/BF01641355
Ceftaroline Activity against Bacterial Pathogens Frequently Isolated in U.S. Medical Centers: Results from Five Years of the AWARE Surveillance Program, Antimicrobial Agents and Chemotherapy, vol.59, issue.4, pp.2458-2461, 2015. ,
DOI : 10.1128/AAC.04614-14
-lactamases, A standard numbering scheme for the class A beta-lactamases », pp.269-270, 1991. ,
DOI : 10.1042/bj2760269
Updated Functional Classification of ??-Lactamases, Antimicrobial Agents and Chemotherapy, vol.54, issue.3, pp.969-976, 2010. ,
DOI : 10.1128/AAC.01009-09
A functional classification scheme for beta-lactamases and its correlation with molecular structure, Antimicrobial Agents and Chemotherapy, vol.39, issue.6, pp.1211-1233, 1995. ,
DOI : 10.1128/AAC.39.6.1211
Diversity, Epidemiology, and Genetics of Class D ??-Lactamases, Antimicrobial Agents and Chemotherapy, vol.54, issue.1, pp.24-38, 2010. ,
DOI : 10.1128/AAC.01512-08
Extended-Spectrum Beta-Lactamases, Seminars in Respiratory and Critical Care Medicine, vol.24, issue.1, pp.657-686, 2005. ,
DOI : 10.1055/s-2003-37919
Growing Group of Extended-Spectrum ??-Lactamases: the CTX-M Enzymes, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.1-14, 2004. ,
DOI : 10.1128/AAC.48.1.1-14.2004
Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae, Nature, vol.87, issue.5007, pp.239-241, 1965. ,
DOI : 10.1099/00221287-33-1-121
??-LACTAMASES, Beta-lactamases », pp.18-27, 1984. ,
DOI : 10.1093/oxfordjournals.bmb.a071942
Extended-Spectrum ??-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat, Clinical Microbiology Reviews, vol.14, issue.4, pp.933-951, 2001. ,
DOI : 10.1128/CMR.14.4.933-951.2001
« beta-Lactamases in laboratory and clinical resistance, Clin. Microbiol. Rev, vol.8, issue.4, pp.557-584, 1995. ,
« SHV-type beta-lactamases », Curr. Pharm. Des, vol.5, issue.11, pp.847-864, 1999. ,
OXA-type beta-lactamases », Curr. Pharm. Des, vol.5, issue.11, pp.865-879, 1999. ,
Molecular and Biochemical Characterization of OXA-45, an Extended-Spectrum Class 2d' ??-Lactamase in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.47, issue.9, pp.2859-2863, 2003. ,
DOI : 10.1128/AAC.47.9.2859-2863.2003
Epidemiology and genetics of CTX-M extended-spectrum ??-lactamases in Gram-negative bacteria, Critical Reviews in Microbiology, vol.52, issue.1, pp.79-101 ,
DOI : 10.1128/AAC.01440-07
Trends in Human Fecal Carriage of Extended-Spectrum ??-Lactamases in the Community: Toward the Globalization of CTX-M, Clinical Microbiology Reviews, vol.26, issue.4, pp.744-758 ,
DOI : 10.1128/CMR.00023-13
Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins., Antimicrobial Agents and Chemotherapy, vol.32, issue.8, pp.1243-1246, 1988. ,
DOI : 10.1128/AAC.32.8.1243
Eine neue plasmidische Cefotaximase in einem Escherichia coli Stamm. Escherichia coli, Infection, vol.17, issue.5, pp.294-298, 1990. ,
DOI : 10.1007/BF01647010
Neue plasmidische Cefotaximase von Patienten mit Salmonella typhimurium-Infektion, Infection, vol.32, issue.3, pp.158-163, 1992. ,
DOI : 10.1128/AAC.32.8.1243
A novel plasmid-medlated extended-spectrum ??-lactamase not derived from TEM- or SHV-type enzymes, Journal of Antimicrobial Chemotherapy, vol.29, issue.5, pp.590-592, 1992. ,
DOI : 10.1093/jac/29.5.590
Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.39, issue.10, pp.2269-2275, 1995. ,
DOI : 10.1128/AAC.39.10.2269
« Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX- M-2 and relationship of their amino acid sequences with those of other betalactamases, Antimicrob. Agents Chemother, vol.40, issue.2, pp.509-513, 1996. ,
« Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaximehydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme, Antimicrob. Agents Chemother, vol.42, issue.4, pp.827-832, 1998. ,
Species in Humans, Clinical Infectious Diseases, vol.33, issue.7, pp.69-74, 2001. ,
DOI : 10.1086/322686
Persistent isolation of Salmonella Concord harbouring CTX-M-15, SHV-12 and QnrA1 in an asymptomatic adopted Ethiopian child in Spain also colonized with CTX-M-14- and QnrB-producing Enterobacteriaceae, Journal of Antimicrobial Chemotherapy, vol.65, issue.7, pp.1545-1546, 2010. ,
DOI : 10.1093/jac/dkq168
Resistance Plasmid Families in Enterobacteriaceae, Resistance plasmid families in Enterobacteriaceae, pp.2227-2238, 2009. ,
DOI : 10.1128/AAC.01707-08
Plasmids in Gram negatives: Molecular typing of resistance plasmids, International Journal of Medical Microbiology, vol.301, issue.8, pp.654-658, 2011. ,
DOI : 10.1016/j.ijmm.2011.09.003
Strains Expressing Extended-Spectrum ??-Lactamase CTX-M-15, Emerging Infectious Diseases, vol.14, issue.2, pp.195-200, 2008. ,
DOI : 10.3201/eid1402.070350
ISCR Elements: Novel Gene-Capturing Systems of the 21st Century?, Microbiology and Molecular Biology Reviews, vol.70, issue.2, pp.296-316, 2006. ,
DOI : 10.1128/MMBR.00048-05
In Vitro Analysis of ISEcp1B-Mediated Mobilization of Naturally Occurring ??-Lactamase Gene blaCTX-M of Kluyvera ascorbata, Antimicrobial Agents and Chemotherapy, vol.50, issue.4, pp.1282-1286, 2006. ,
DOI : 10.1128/AAC.50.4.1282-1286.2006
Novel plasmid-mediated CTX-M-8 subgroup extended-spectrum ??-lactamase (CTX-M-40) isolated in the UK, International Journal of Antimicrobial Agents, vol.27, issue.6, pp.572-575, 2006. ,
DOI : 10.1016/j.ijantimicag.2006.03.003
Effect of spacer sequences between blaCTX-M and ISEcp1 on blaCTX-M expression, Journal of Medical Microbiology, vol.60, issue.12, pp.1787-1792 ,
DOI : 10.1099/jmm.0.033910-0
Genetic support and diversity of acquired extended-spectrum ??-lactamases in Gram-negative rods, Infection, Genetics and Evolution, vol.12, issue.5, pp.883-893, 2012. ,
DOI : 10.1016/j.meegid.2012.02.008
Iredell, « Complete sequence of pJIE143, a pir-type plasmid carrying ISEcp1-blaCTX- M-15 from an Escherichia coli ST131 isolate, Antimicrob. Agents Chemother, vol.55, pp.12-5933, 2011. ,
Regional outbreak of CTX-M-2 ??-lactamase-producing Proteus mirabilis in Japan, Journal of Medical Microbiology, vol.61, issue.Pt_12, pp.1727-1735 ,
DOI : 10.1099/jmm.0.049726-0
Countrywide Spread of CTX-M-3 Extended-Spectrum ??-Lactamase-Producing Microorganisms of the Family Enterobacteriaceae in Poland, Antimicrobial Agents and Chemotherapy, vol.46, issue.1, pp.151-159, 2002. ,
DOI : 10.1128/AAC.46.1.151-159.2002
Complete nucleotide sequence of pHN7A8, an F33:A-:B-type epidemic plasmid carrying blaCTX-M-65, fosA3 and rmtB from China, Journal of Antimicrobial Chemotherapy, vol.68, issue.1, pp.46-50, 2013. ,
DOI : 10.1093/jac/dks369
Spread of bla(CTX-M- 14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain, Antimicrob. Agents Chemother, vol.53, pp.12-5204, 2009. ,
Detection and characterization of pCT-like plasmid vectors for blaCTX-M-14 in Escherichia coli isolates from humans, turkeys and cattle in England and Wales, Journal of Antimicrobial Chemotherapy, vol.67, issue.7, pp.1639-1644 ,
DOI : 10.1093/jac/dks126
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance, FEMS Microbiology Reviews, vol.35, issue.5, pp.736-755, 2011. ,
DOI : 10.1111/j.1574-6976.2011.00268.x
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain, Journal of Antimicrobial Chemotherapy, vol.66, issue.1, pp.1-14 ,
DOI : 10.1093/jac/dkq415
Clones, Microbial Drug Resistance, vol.17, issue.1, pp.83-97, 2011. ,
DOI : 10.1089/mdr.2010.0132
« Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131, et Spanish Network in Infectious Pathology Project (REIPI) Int. J. Antimicrob. Agents, vol.34, issue.2, pp.173-176, 2009. ,
Multi-Locus Sequence Typing of Enteroaggregative Escherichia coli Isolates from Nigerian Children Uncovers Multiple Lineages, Multi-locus sequence typing of enteroaggregative Escherichia coli isolates from Nigerian children uncovers multiple lineages, p.14093, 2010. ,
DOI : 10.1371/journal.pone.0014093.s006
Clinical Isolates in Cairo (Egypt), Including Isolates of Clonal Complex ST10 and Clones ST131, ST73, and ST405 in Both Community and Hospital Settings, CTX-M-15- producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings, pp.67-73, 2011. ,
DOI : 10.1089/mdr.2010.0063
Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America, Clinical Microbiology and Infection, vol.19, issue.4, pp.356-361, 2013. ,
DOI : 10.1111/j.1469-0691.2012.03807.x
Clonal Structure, Extended-Spectrum ??-Lactamases, and Acquired AmpC-Type Cephalosporinases of Escherichia coli Populations Colonizing Patients in Rehabilitation Centers in Four Countries, Antimicrobial Agents and Chemotherapy, vol.57, issue.1, pp.309-316 ,
DOI : 10.1128/AAC.01656-12
Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type ??-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?, Journal of Antimicrobial Chemotherapy, vol.62, issue.5, pp.978-985, 2005. ,
DOI : 10.1093/jac/dkn287
Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults, Journal of Antimicrobial Chemotherapy, vol.64, issue.3, pp.35-524, 2009. ,
DOI : 10.1093/jac/dkp211
High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination, International Journal of Antimicrobial Agents, vol.38, issue.2, pp.160-163, 2011. ,
DOI : 10.1016/j.ijantimicag.2011.03.020
Spread of blaCTX-M-type and blaPER-2 ??-lactamase genes in clinical isolates from Bolivian hospitals, Journal of Antimicrobial Chemotherapy, vol.57, issue.5, pp.975-978, 2006. ,
DOI : 10.1093/jac/dkl055
Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1causing infections in Brazilian tertiary-care hospital, BMC Infectious Diseases, vol.31, issue.6, p.176, 2012. ,
DOI : 10.1016/j.ijantimicag.2008.01.020
Nosocomial Transmission of CTX-M-2 ??-Lactamase-Producing Acinetobacter baumannii in a Neurosurgery Ward, Journal of Clinical Microbiology, vol.42, issue.9, pp.3978-3984, 2004. ,
DOI : 10.1128/JCM.42.9.3978-3984.2004
Genetic Features of CTX-M-15-Producing Acinetobacter baumannii from Haiti, Antimicrobial Agents and Chemotherapy, vol.55, issue.12, pp.12-5946, 2011. ,
DOI : 10.1128/AAC.05124-11
Plasmidic Extended-Spectrum ??-Lactamases in Vibrio cholerae O1 El Tor Isolates in Argentina, Antimicrobial Agents and Chemotherapy, vol.46, issue.5, pp.1462-1468, 2002. ,
DOI : 10.1128/AAC.46.5.1462-1468.2002
Osteomyelitis associated to CTX-M-15-producing Aeromonas hydrophila: First description in the literature, Diagnostic Microbiology and Infectious Disease, vol.70, issue.3, pp.420-422, 2011. ,
DOI : 10.1016/j.diagmicrobio.2011.03.004
A CTX-M extended-spectrum ??-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia, Journal of Medical Microbiology, vol.55, issue.11, pp.1607-1608, 2006. ,
DOI : 10.1099/jmm.0.46704-0
« In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases, J. Chemother. Florence Italy, vol.8, issue.2, pp.57-62, 1996. ,
Mutation in Serratia marcescens AmpC ??-Lactamase Producing High-Level Resistance to Ceftazidime and Cefpirome, Antimicrobial Agents and Chemotherapy, vol.45, issue.8, pp.2331-2339, 2001. ,
DOI : 10.1128/AAC.45.8.2331-2339.2001
??-Laktamase in Klebsiella pneumoniae mit erweitertem Breitspektrum einschlie??lich Resistenz gegen Cephamycine, Infection, vol.37, issue.5, pp.316-321, 1989. ,
DOI : 10.1007/BF01650718
Extended-spectrum beta-lactamases and the permeability barrier, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.14, 2008. ,
Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates., Antimicrobial Agents and Chemotherapy, vol.34, issue.5, pp.755-758, 1990. ,
DOI : 10.1128/AAC.34.5.755
« Characterization of IMI-1 beta-lactamase, a class A carbapenemhydrolyzing enzyme from Enterobacter cloacae, Antimicrob. Agents Chemother, vol.40, issue.9, pp.2080-2086, 1996. ,
Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City, Archives of Internal Medicine, vol.165, issue.12, pp.12-1430, 2005. ,
DOI : 10.1001/archinte.165.12.1430
Plasmid-Mediated Carbapenem-Hydrolyzing ??-Lactamase KPC in a Klebsiella pneumoniae Isolate from France, Antimicrobial Agents and Chemotherapy, vol.49, issue.10, pp.4423-4424, 2005. ,
DOI : 10.1128/AAC.49.10.4423-4424.2005
Nosocomial outbreak of Klebsiella pneumoniae harbouring blaKPC-3 in France subsequent to a patient transfer from Italy, International Journal of Antimicrobial Agents, vol.39, issue.5, pp.448-449, 2012. ,
DOI : 10.1016/j.ijantimicag.2012.01.008
Gene1, Emerging Infectious Diseases, vol.16, issue.9, pp.1349-1356, 2010. ,
DOI : 10.3201/eid1609.091389
Functional Characterization of Tn4401, a Tn3-Based Transposon Involved in blaKPC Gene Mobilization, Antimicrobial Agents and Chemotherapy, vol.55, issue.11, pp.5370-5373 ,
DOI : 10.1128/AAC.05202-11
IMP-type metallo-??-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons, Critical Reviews in Microbiology, vol.36, issue.4, pp.214-226, 2011. ,
DOI : 10.3109/1040841X.2010.481763
Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens, Antimicrobial Agents and Chemotherapy, vol.39, issue.4, pp.824-829, 1995. ,
DOI : 10.1128/AAC.39.4.824
Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate, Antimicrob. Agents Chemother, vol.43, issue.7, pp.1584-1590, 1999. ,
Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-beta -Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France, Antimicrobial Agents and Chemotherapy, vol.44, issue.4, pp.891-897, 2000. ,
DOI : 10.1128/AAC.44.4.891-897.2000
Epidemiology and genetics of VIM-type metallo-??-lactamases in Gram-negative bacilli, Future Microbiology, vol.54, issue.3, pp.317-333, 2011. ,
DOI : 10.1093/jac/dkq190
« Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India, Antimicrob. Agents Chemother, vol.53, pp.12-5046, 2009. ,
Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge, M??decine et Maladies Infectieuses, vol.44, issue.2, pp.51-56, 2014. ,
DOI : 10.1016/j.medmal.2013.11.007
Global spread of New Delhi metallo-??-lactamase 1, The Lancet Infectious Diseases, vol.10, issue.12, pp.12-832, 2010. ,
DOI : 10.1016/S1473-3099(10)70279-6
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study, Lancet Infect. Dis, vol.10, issue.9, pp.597-602, 2010. ,
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae, Journal of Antimicrobial Chemotherapy, vol.66, issue.10, pp.2295-2297 ,
DOI : 10.1093/jac/dkr296
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, pp.15-22, 2004. ,
DOI : 10.1128/AAC.48.1.15-22.2004
Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey, Antimicrobial Agents and Chemotherapy, vol.52, issue.8, pp.2950-2954, 2008. ,
DOI : 10.1128/AAC.01672-07
Nordmann, « European dissemination of a single OXA-48-producing Klebsiella pneumoniae clone, Clin. Microbiol. Infect ,
Winterhalter, « The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria, Nat. Rev. Microbiol, vol.6, pp.12-893, 2008. ,
Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes, Journal of Medical Microbiology, vol.40, issue.6, pp.403-407, 1994. ,
DOI : 10.1099/00222615-40-6-403
Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK, Journal of Antimicrobial Chemotherapy, vol.63, issue.4, pp.659-667, 2009. ,
DOI : 10.1093/jac/dkp029
« Emergence of carbapenem-resistant Escherichia coli in Taiwan: resistance due to combined CMY-2 production and porin deficiency, J. Chemother ,
Imipenem Resistance in Salmonella enterica Serovar Wien Related to Porin Loss and CMY-4 ??-Lactamase Production, Antimicrobial Agents and Chemotherapy, vol.47, issue.3, pp.1165-1168, 2003. ,
DOI : 10.1128/AAC.47.3.1165-1168.2003
An Ertapenem-Resistant Extended-Spectrum-??-Lactamase-Producing Klebsiella pneumoniae Clone Carries a Novel OmpK36 Porin Variant, Antimicrobial Agents and Chemotherapy, vol.54, issue.10, pp.4178-4184, 2010. ,
DOI : 10.1128/AAC.01301-09
« Multidrug-resistant, extensively drug-resistant and pandrugresistant bacteria: an international expert proposal for interim standard definitions for acquired resistance, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.18, issue.3, pp.268-281, 2012. ,
Faecal carriage of extended-spectrum ??-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology, Journal of Antimicrobial Chemotherapy, vol.62, issue.5, pp.1142-1149, 2008. ,
DOI : 10.1093/jac/dkn293
Cantón, « CTX-M-15-non-ST131 Escherichia coli isolates are mainly responsible of faecal carriage with ESBLproducing Enterobacteriaceae in travellers, immigrants and those visiting friends and relatives, Clin. Microbiol. Infect, vol.21, issue.3, pp.252-253, 2015. ,
Escherichia coli ST131, an Intriguing Clonal Group, Clinical Microbiology Reviews, vol.27, issue.3, pp.543-574 ,
DOI : 10.1128/CMR.00125-13
URL : https://hal.archives-ouvertes.fr/hal-01061609
Animal reservoirs for extended spectrum beta-lactamase producers, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.14, 2008. ,
« Extendedspectrum ?-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.18, issue.7, pp.646-655, 2012. ,
Increase in hospital-acquired bloodstream infections caused by extended spectrum ??-lactamase-producing Escherichia coli in a large French teaching hospital, European Journal of Clinical Microbiology & Infectious Diseases, vol.10, issue.9, pp.491-498, 2009. ,
DOI : 10.3201/eid1009.030969
Dramatic Increase in Prevalence of Fecal Carriage of Extended-Spectrum ??-Lactamase-Producing Enterobacteriaceae during Nonoutbreak Situations in Spain, Journal of Clinical Microbiology, vol.42, issue.10, pp.4769-4775, 2004. ,
DOI : 10.1128/JCM.42.10.4769-4775.2004
10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum ??-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre, Journal of Antimicrobial Chemotherapy, vol.68, issue.3, pp.562-568, 2013. ,
DOI : 10.1093/jac/dks429
URL : https://hal.archives-ouvertes.fr/hal-00802788
Clinical impact and risk factors for colonization with extended-spectrum ??-lactamase-producing bacteria in the intensive care unit, Intensive Care Medicine, vol.171, issue.Suppl 1, pp.1769-1778, 2012. ,
DOI : 10.1164/rccm.200405-644ST
Extended-spectrum beta-lactamase?????????producing enterobacteriaceae in the intensive care unit: acquisition does not mean cross-transmission, BMC Infectious Diseases, vol.40, issue.4, p.147, 2016. ,
DOI : 10.1007/s00134-014-3225-8
URL : https://hal.archives-ouvertes.fr/hal-01304295
Fecal carriage of extended-spectrum ??-lactamase-producing Enterobacteriaceae in Korean community and hospital settings, Infection, vol.42, issue.1, pp.9-13 ,
DOI : 10.1128/JCM.42.3.1089-1094.2004
and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis, Clinical Infectious Diseases, vol.63, issue.3, pp.310-318, 2016. ,
DOI : 10.1093/cid/ciw283
Extended spectrum ??-lactamase producing Enterobacteriaceae in Lebanese ICU patients: Epidemiology and patterns of resistance, The Journal of General and Applied Microbiology, vol.52, issue.3, pp.169-178, 2006. ,
DOI : 10.2323/jgam.52.169
Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome, Journal of Antimicrobial Chemotherapy, vol.63, issue.3, pp.568-574, 2009. ,
DOI : 10.1093/jac/dkn514
Risk Factors and Prognosis, et Spanish Network for Research in Infectious Diseases (REIPI), pp.40-48, 2010. ,
DOI : 10.1086/649537
An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: Incidence, risk factors and its impact on outcome, European Journal of Internal Medicine, vol.23, issue.2, pp.192-195, 2012. ,
DOI : 10.1016/j.ejim.2011.06.016
and Infection after Liver Transplant, France, Emerging Infectious Diseases, vol.18, issue.6, pp.908-916, 2012. ,
DOI : 10.3201/eid1806.110139
« Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies », Support. Care Cancer Off, J. Multinatl. Assoc. Support. Care Cancer, vol.24, issue.1, pp.253-259 ,
Risk factors for, and clinical relevance of, faecal extended-spectrum ??-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies, European Journal of Clinical Microbiology & Infectious Diseases, vol.18, issue.3 ,
DOI : 10.1128/CMR.18.4.657-686.2005
Significance of Prior Digestive Colonization With Extended-Spectrum ??-Lactamase???Producing Enterobacteriaceae in Patients With Ventilator-Associated Pneumonia, Critical Care Medicine, vol.44, issue.4, pp.699-706, 2016. ,
DOI : 10.1097/CCM.0000000000001471
The gut is the epicentre of antibiotic resistance, Antimicrobial Resistance and Infection Control, vol.1, issue.1, pp.39-2012 ,
DOI : 10.1093/cid/cir025
Rate of Transmission of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Without Contact Isolation, Clinical Infectious Diseases, vol.55, issue.11, pp.1505-1511 ,
DOI : 10.1093/cid/cis770
How important is patient-to-patient transmission in extended-spectrum ??-lactamase Escherichia coli acquisition, American Journal of Infection Control, vol.35, issue.2, pp.97-101, 2007. ,
DOI : 10.1016/j.ajic.2006.09.011
Patient-to-Patient Transmission Is Important in Extended-Spectrum ??-Lactamase-Producing Klebsiella pneumoniae Acquisition, Clinical Infectious Diseases, vol.45, issue.10, pp.1347-1350, 2007. ,
DOI : 10.1086/522657
Extended-spectrum betalactamases Klebsiella pneumoniae: multimodal infection control program in intensive care units, J. Prev. Med. Hyg, vol.51, issue.3, pp.110-115, 2010. ,
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene, The Lancet, vol.356, issue.9238, pp.9238-1307, 2000. ,
DOI : 10.1016/S0140-6736(00)02814-2
Adverse effects of isolation in hospitalised patients: a systematic review, Journal of Hospital Infection, vol.76, issue.2, pp.97-102, 2010. ,
DOI : 10.1016/j.jhin.2010.04.027
Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour, Critical Care Medicine, vol.42, issue.8, pp.1749-1755, 2014. ,
DOI : 10.1097/CCM.0000000000000330
Colonization and infection with extended-spectrum ??-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?, Journal of Antimicrobial Chemotherapy, vol.71, issue.4, pp.1088-1097 ,
DOI : 10.1093/jac/dkv423
« Decolonization of intestinal carriage of extended-spectrum ?-lactamaseproducing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial, J. Antimicrob. Chemother, vol.68, issue.10, pp.2375-2382 ,
Intestinal decolonization of Enterobacteriaceae producing extended-spectrum ??-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature, BMC Infectious Diseases, vol.53, issue.1, p.475, 2015. ,
DOI : 10.1128/JCM.00378-15
in Adults, JAMA, vol.313, issue.4, pp.398-408, 2015. ,
DOI : 10.1001/jama.2014.17103
Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease, Clinical Microbiology and Infection, vol.20, issue.11, pp.977-978, 2014. ,
DOI : 10.1111/1469-0691.12683
Ballon-Landa, « Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization, J. Clin. Microbiol, vol.53, issue.6, 2015. ,
Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU, Intensive Care Medicine, vol.42, issue.5, pp.862-870, 2009. ,
DOI : 10.3201/eid1308.070071
Gruson, « Control of extended-spectrum ?-lactamase-producing Enterobacteriaceae nosocomial acquisition in an intensive care unit: A time series regression analysis », Am, J. Infect. Control, vol.43, pp.12-1296 ,
Prospective Study of Fecal Colonization by Extended-Spectrum-??-Lactamase-Producing Escherichia coli in Neutropenic Patients with Cancer, Antimicrobial Agents and Chemotherapy, vol.52, issue.11, pp.4187-4190, 2008. ,
DOI : 10.1128/AAC.00367-08
Alternatives to carbapenems in ESBL-producing Escherichia coli infections, Alternatives to carbapenems in ESBL-producing Escherichia coli infections, pp.62-66 ,
DOI : 10.1016/j.medmal.2013.01.006
URL : https://hal.archives-ouvertes.fr/hal-00802661
« Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extendedspectrum beta-lactamase-producing Enterobacteriaceae, Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis, vol.29, pp.91-95, 2014. ,
Pharmacokinetics-Pharmacodynamics of Cefepime and Piperacillin- Tazobactam against Escherichia coli and Klebsiella pneumoniae Strains Producing Extended-Spectrum ??-Lactamases: Report from the ARREST Program, Antimicrobial Agents and Chemotherapy, vol.47, issue.5, pp.1643-1646, 2003. ,
DOI : 10.1128/AAC.47.5.1643-1646.2003
Pascual, « Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillintazobactam with extended-spectrum beta-lactamase-producing and extendedspectrum beta-lactamase-non-producing Escherichia coli isolates ,
??-Lactam/??-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum ??-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts, Clinical Infectious Diseases, vol.54, issue.2, pp.167-174, 2012. ,
DOI : 10.1093/cid/cir790
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum ??-lactamases: a systematic review and meta-analysis, Journal of Antimicrobial Chemotherapy, vol.67, issue.12, pp.12-2793 ,
DOI : 10.1093/jac/dks301
??-lactam and ??-lactamase inhibitor combinations in the treatment of extended-spectrum ??-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?, The Lancet Infectious Diseases, vol.15, issue.4, pp.475-485, 2015. ,
DOI : 10.1016/S1473-3099(14)70950-8
et for the Antibacterial Resistance Leadership Group, « Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum -Lactamase Bacteremia, Clin. Infect. Dis, 2015. ,
Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-??-Lactamase-Producing Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.57, issue.7, pp.3402-3404, 2013. ,
DOI : 10.1128/AAC.00135-13
Teng, « Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting, J. Antimicrob. Chemother, vol.70, issue.4, pp.1219-1225 ,
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients, Antimicrobial Agents and Chemotherapy, vol.57, issue.3, pp.1488-1495, 2013. ,
DOI : 10.1128/AAC.01823-12
Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs, Clinical Infectious Diseases, vol.59, issue.suppl_3, pp.134-145 ,
DOI : 10.1093/cid/ciu547
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI), Clinical Infectious Diseases, vol.60, issue.10, pp.1462-1471, 2015. ,
DOI : 10.1093/cid/civ097
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate: TABLE 1, Antimicrobial Agents and Chemotherapy, vol.59, issue.10, pp.6605-6607, 2015. ,
DOI : 10.1128/AAC.01165-15
Fecal Carriage of Extended-Spectrum ??-Lactamase???Producing Escherichia coli and Klebsiella pneumoniae in Patients and Asymptomatic Healthy Individuals, Infection Control & Hospital Epidemiology, vol.37, issue.09, pp.1114-1116, 2007. ,
DOI : 10.1007/s10096-003-1084-2
Prospective survey of digestive tract colonization with enterobacteriaceae that produce extended-spectrum ??-lactamases in intensive care units, Journal of Hospital Infection, vol.62, issue.3, pp.386-388, 2006. ,
DOI : 10.1016/j.jhin.2005.09.014
Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units, Journal of Antimicrobial Chemotherapy, vol.67, issue.6, pp.1525-1536, 2012. ,
DOI : 10.1093/jac/dks072
Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-Producing Enterobacteriaceae Strains Containing the aac(6')-Ib-cr Gene, Which Encodes an Aminoglycoside- and Fluoroquinolone-Modifying Enzyme, Antimicrobial Agents and Chemotherapy, vol.50, issue.9, pp.3220-3221, 2006. ,
DOI : 10.1128/AAC.00473-06
Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase???Producing Enterobacteriaceae: MIC Matters, Clinical Infectious Diseases, vol.56, issue.4, pp.488-495 ,
DOI : 10.1093/cid/cis916
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies, Journal of Antimicrobial Chemotherapy, vol.62, issue.5, 2008. ,
DOI : 10.1093/jac/dkn311
Clinical Significance of the Pharmacokinetic and Pharmacodynamic Characteristics of Tigecycline, Current Drug Metabolism, vol.10, issue.1, pp.13-21, 2009. ,
DOI : 10.2174/138920009787048356
In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli, European Journal of Clinical Microbiology & Infectious Diseases, vol.9, issue.9, pp.981-987, 2011. ,
DOI : 10.1517/14656566.9.9.1441
Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum ??-lactamase-producing organisms in a non-outbreak setting, Journal of Hospital Infection, vol.65, issue.4, pp.354-360, 2007. ,
DOI : 10.1016/j.jhin.2006.12.014